Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.8/5
3SBio Inc (1530 HK)
Watchlist
Contact IR
130
Analysis
Health Care
•
China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
03 Aug 2016 11:56
Chinese Choose Not to Have More Children
Chinese people are actively choosing not to have further children and this will lead inexorably to a population collapse during the balance of this...
Bixmoor
305 Views
Share
bullish
•
China Nepstar Chain Drugstore
•
17 Mar 2016 10:00
Just What the Doctor Ordered
This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling...
Crispin Francis
377 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Feb 2016 21:38
Coming to the HKEX Soon....................
Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...
Kemp Dolliver, CFA
315 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Feb 2016 15:01
Time to Go Shopping for Healthcare
The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...
Kemp Dolliver, CFA
333 Views
Share
bullish
•
3SBio Inc
•
27 Jan 2016 02:48
China's FDA Ups Its Game
One of the pharmaceutical industry’s main complaints about China is the extremely slow drug approval process. The approval process in China...
Kemp Dolliver, CFA
375 Views
Share
First
Previous
21
22
23
24
25
26
27
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.1
x